Reveal your hidden biology
Improve your mental health
Protect your future
Dionysus Digital Health
Molecular Diagnostics for Breakthroughs in Maternal Mental Health
We need to do better for our moms and babies. At Dionysus Health, we’re leading that change. We are a molecular diagnostics company pioneering innovations in maternal mental health—starting with myLuma™, the first prenatal blood test that predicts a woman’s risk of postpartum depression as early as 28 weeks into pregnancy.
Postpartum depression is the #1 complication of childbirth, yet nearly a quarter of affected women receive no treatment. Our goal is to replace delayed, self-reported screening with clinically validated diagnostics—delivering early, actionable insights to patients, providers, and health systems, and transforming maternal care through precision and prevention.